Related references
Note: Only part of the references are listed.Allogeneic hematopoietic cell transplantation in patients with myeloid/lymphoid neoplasm with FGFR1-rearrangement: a study of the Chronic Malignancies Working Party of EBMT
Juan-Carlos Hernandez-Boluda et al.
BONE MARROW TRANSPLANTATION (2022)
World Health Organization-defined eosinophilic disorders: 2022 update on diagnosis, risk stratification, and management
William Shomali et al.
AMERICAN JOURNAL OF HEMATOLOGY (2022)
PCM1-JAK2 Fusion Tyrosine Kinase Gene-Related Neoplasia: A Systematic Review of the Clinical Literature
Henry G. Kaplan et al.
ONCOLOGIST (2022)
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
Daniel A. Arber et al.
BLOOD (2022)
Partial Response to Sorafenib in a Child With a Myeloid/Lymphoid Neoplasm, Eosinophilia, and a ZMYM2-FLT3 Fusion
Monica C. Munthe-Kaas et al.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2021)
Myeloid/Lymphoid Neoplasms Associated With Eosinophilia and Rearrangements of PDGFRA, PDGFRB, or FGFR1 or With PCM1-JAK2
Olga Pozdnyakova et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2021)
Eosinophilia/Hypereosinophilia in the Setting of Reactive and Idiopathic Causes, Well-Defined Myeloid or Lymphoid Leukemias, or Germline Disorders Report of the 2019 Society for Hematopathology/European Association for Haematopathology Workshop
Katalin Kelemen et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2021)
Myeloid/lymphoid neoplasms with FLT3 rearrangement
Guilin Tang et al.
MODERN PATHOLOGY (2021)
Eosinophils and eosinophil-associated disorders: immunological, clinical, and molecular complexity
Peter Valent et al.
SEMINARS IN IMMUNOPATHOLOGY (2021)
Lymphoid blast transformation in an MPN with BCR-JAK2 treated with ruxolitinib: putative mechanisms of resistance
Justin Anthony Chen et al.
BLOOD ADVANCES (2021)
Myeloid/lymphoid neoplasm with CEP110-FGFR1 fusion: An analysis of 16 cases show common features and poor prognosis
Meiyu Chen et al.
HEMATOLOGY (2021)
Fusion driven JMML: a novel CCDC88C-FLT3 fusion responsive to sorafenib identified by RNA sequencing
Alexander K. Chao et al.
LEUKEMIA (2020)
Systematic use of fluorescence in-situ hybridisation and clinicopathological features in the screening of PDGFRB rearrangements of patients with myeloid/lymphoid neoplasms
Hong Fang et al.
HISTOPATHOLOGY (2020)
Response to tyrosine kinase inhibitors in myeloid neoplasms associated with PCM1-JAK2, BCR-JAK2 and ETV6-ABL1 fusion genes
Juliana Schwaab et al.
AMERICAN JOURNAL OF HEMATOLOGY (2020)
Transformation to erythroblastic sarcoma from myeloid neoplasm with PCM1-JAK2
Catherine Luedke et al.
BLOOD (2020)
A Cryptic BCR-PDGFRB Fusion Resulting in a Chronic Myeloid Neoplasm With Monocytosis and Eosinophilia: A Novel Finding With Treatment Implications
Sanjeev Kumar Gupta et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2020)
Myeloid/lymphoid neoplasms with eosinophilia and FLT3 rearrangement
Haipeng Shao et al.
LEUKEMIA RESEARCH (2020)
A cryptic imatinib-sensitive G3BP1-PDGFRB rearrangement in a myeloid neoplasm with eosinophilia
Max Jan et al.
BLOOD ADVANCES (2020)
Chronic myelomonocytic leukemia with ETV6-ABL1 rearrangement and SMC1A mutation
Melissa H. Cessna et al.
CANCER GENETICS (2019)
Recurrent activating STAT5B N642H mutation in myeloid neoplasms with eosinophilia
Nicholas C. P. Cross et al.
LEUKEMIA (2019)
Hematopoietic neoplasms with 9p24/JAK2 rearrangement: a multicenter study
Guilin Tang et al.
MODERN PATHOLOGY (2019)
Myeloid/lymphoid neoplasms with FGFR1 rearrangement
Paolo Strati et al.
LEUKEMIA & LYMPHOMA (2018)
A Test Utilization Approach to the Diagnostic Workup of Isolated Eosinophilia in Otherwise Morphologically Unremarkable Bone Marrow A Single Institutional Experience
Hong Fang et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2018)
Treatment of the myeloid/lymphoid neoplasm with FGFR1 rearrangement with FGFR1 inhibitor
S. Verstovsek et al.
ANNALS OF ONCOLOGY (2018)
Genomic and outcome analyses of Ph-like ALL in NCI standard-risk patients: a report from the Children's Oncology Group
Kathryn G. Roberts et al.
BLOOD (2018)
Molecular genetic characterization of myeloid/lymphoid neoplasms associated with eosinophilia and rearrangement of PDGFRA, PDGFRB, FGFR1 or PCM1-JAK2
Constance Baer et al.
HAEMATOLOGICA (2018)
Clinical outcomes of myeloid/lymphoid neoplasms with fibroblast growth factor receptor-1 (FGFR1) rearrangement
Kento Umino et al.
HEMATOLOGY (2018)
Molecular genetic characterization of myeloid/lymphoid neoplasms associated with eosinophilia and rearrangement of PDGFRA, PDGFRB, FGFR1 or PCM1-JAK2
Constance Baer et al.
HAEMATOLOGICA (2018)
A multimodality work-up of patients with Hypereosinophilia
Zhihong Hu et al.
AMERICAN JOURNAL OF HEMATOLOGY (2018)
Myeloproliferative neoplasm with ABL1/ETV6 rearrangement mimics chronic myeloid leukemia and responds to tyrosine kinase inhibitors
Wei Xie et al.
CANCER GENETICS (2018)
Prognostic impact of kinase-activating fusions and IKZF1 deletions in pediatric high-risk B-lineage acute lymphoblastic leukemia
Thai Hoa Tran et al.
BLOOD ADVANCES (2018)
Two myeloid leukemia cases with rare FLT3 fusions
Haijiao Zhang et al.
COLD SPRING HARBOR MOLECULAR CASE STUDIES (2018)
A novel t(3;13)(q13;q12) translocation fusing FLT3 with GOLGB1: toward myeloid/lymphoid neoplasms with eosinophilia and rearrangement of FLT3?
E. Troadec et al.
LEUKEMIA (2017)
Bone marrow morphology is a strong discriminator between chronic eosinophilic leukemia, not otherwise specified and reactive idiopathic hypereosinophilic syndrome
Sa A. Wang et al.
HAEMATOLOGICA (2017)
Myeloproliferative neoplasms with t(8;22)(p11.2;q11.2)/BCR-FGFR1: a meta-analysis of 20 cases shows cytogenetic progression with B-lymphoid blast phase
Ximena Montenegro-Garreaud et al.
HUMAN PATHOLOGY (2017)
Cytogenetically cryptic ZMYM2-FLT3 and DIAPH1-PDGFRB gene fusions in myeloid neoplasms with eosinophilia
M. Jawhar et al.
LEUKEMIA (2017)
A novel TRIP11-FLT3 fusion in a patient with a myeloid/lymphoid neoplasm with eosinophilia
Alfred Chung et al.
CANCER GENETICS (2017)
Bone marrow morphology is a strong discriminator between chronic eosinophilic leukemia, not otherwise specified and reactive idiopathic hypereosinophilic syndrome
Sa A. Wang et al.
HAEMATOLOGICA (2017)
Philadelphia chromosome-like acute lymphoblastic leukemia
Sarah K. Tasian et al.
BLOOD (2017)
Guideline for the investigation and management of eosinophilia
Nauman M. Butt et al.
BRITISH JOURNAL OF HAEMATOLOGY (2017)
The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia
Daniel A. Arber et al.
BLOOD (2016)
Characterization of leukemias with ETV6-ABL1 fusion
Marketa Zaliova et al.
HAEMATOLOGICA (2016)
Cytogenetic Evolution Associated With Disease Progression in Hematopoietic Neoplasms With t(8;22)(p11; q11)/BCR-FGFR1 Rearrangement
Wei Wang et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2016)
Predictors of survival in WHO-defined hypereosinophilic syndrome and idiopathic hypereosinophilia and the role of next-generation sequencing
A. Pardanani et al.
LEUKEMIA (2016)
Targeted next-generation sequencing identifies a subset of idiopathic hypereosinophilic syndrome with features similar to chronic eosinophilic leukemia, not otherwise specified
Sa A. Wang et al.
MODERN PATHOLOGY (2016)
Long-term outcomes of imatinib in patients with FIP1L1/PDGFRA associated chronic eosinophilic leukemia: experience of a single center in china
Shi-Qiang Qu et al.
ONCOTARGET (2016)
Characterization of leukemias with ETV6-ABL1 fusion
Marketa Zaliova et al.
HAEMATOLOGICA (2016)
Efficacy of ruxolitinib in myeloid neoplasms with PCM1-JAK2 fusion gene
Elisa Rumi et al.
ANNALS OF HEMATOLOGY (2015)
Limited duration of complete remission on ruxolitinib in myeloid neoplasms with PCM1-JAK2 and BCR-JAK2 fusion genes
Juliana Schwaab et al.
ANNALS OF HEMATOLOGY (2015)
Successful allogeneic stem cell transplantation with long-term remission of ETV6/FLT3-positive myeloid/lymphoid neoplasm with eosinophilia
Kazuhisa Chonabayashi et al.
ANNALS OF HEMATOLOGY (2014)
Should myeloid and lymphoid neoplasms with PCM1-JAK2 and other rearrangements of JAK2 be recognized as specific entities?
Barbara J. Bain et al.
BRITISH JOURNAL OF HAEMATOLOGY (2014)
Identification of Ponatinib as a potent inhibitor of growth, migration, and activation of neoplastic eosinophils carrying FIP1L1-PDGFRA
Irina Sadovnik et al.
EXPERIMENTAL HEMATOLOGY (2014)
ETV6-FLT3 fusion gene-positive, eosinophilia-associated myeloproliferative neoplasm successfully treated with sorafenib and allogeneic stem cell transplant
L. Falchi et al.
LEUKEMIA (2014)
Targetable Kinase-Activating Lesions in Ph-like Acute Lymphoblastic Leukemia
K. G. Roberts et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
ETV6/FLT3 fusion in a mixed-phenotype acute leukemia arising in lymph nodes in a patient with myeloproliferative neoplasm with eosinophilia
Niloufar Hosseini et al.
JOURNAL OF HEMATOPATHOLOGY (2014)
Ruxolitinib inhibits transforming JAK2 fusion proteins in vitro and induces complete cytogenetic remission in t(8;9)(p22;p24)/PCM1-JAK2-positive chronic eosinophilic leukemia
Els Lierman et al.
BLOOD (2012)
Contemporary consensus proposal on criteria and classification of eosinophilic disorders and related syndromes
Peter Valent et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2012)
Novel imatinib-sensitive PDGFRA-activating point mutations in hypereosinophilic syndrome induce growth factor independence and leukemia-like disease
Christian Elling et al.
BLOOD (2011)
Response of ETV6-FLT3-positive myeloid/lymphoid neoplasm with eosinophilia to inhibitors of FMS-like tyrosine kinase 3
Christoph Walz et al.
BLOOD (2011)
Identification of FOXP1 and SNX2 as novel ABL1 fusion partners in acute lymphoblastic leukaemia
Thomas Ernst et al.
BRITISH JOURNAL OF HAEMATOLOGY (2011)
ABL1 fusion genes in hematological malignancies: a review
Etienne De Braekeleer et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2011)
ETV6-ABL1-positive chronic myeloid leukemia: clinical and molecular response to tyrosine kinase inhibition
Fabiana Perna et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2011)
Molecular characterization of paediatric idiopathic hypereosinophilia
Maria Cristina Rapanotti et al.
BRITISH JOURNAL OF HAEMATOLOGY (2010)
FIP1L1-PDGFRα D842V, a novel panresistant mutant, emerging after treatment of FIP1L1-PDGFRα T674I eosinophilic leukemia with single agent sorafenib
E. Lierman et al.
LEUKEMIA (2009)
t(8;13)-positive bilineal lymphomas - Report of 6 cases
Francisco Vega et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2008)
Novel SSBP2-JAK2 fusion gene resulting from a t(5;9)(q14.1;p24.1) in pre-B acute lymphocytic leukemia
Jennifer L. Poitras et al.
GENES CHROMOSOMES & CANCER (2008)
Systemic mastocytosis with associated myeloproliferative disease and precursor B lymphoblastic leukaemia with t(13;13)(q12;q22) involving FLT3
A. Tzankov et al.
JOURNAL OF CLINICAL PATHOLOGY (2008)
Numerical gain and structural rearrangements of JAK2, identified by FISH, characterize both JAK2617V>F-positive and -negative patients with Ph-negative MPD, myelodysplasia, and B-lymphoid neoplasms
Vesna Naifeld et al.
EXPERIMENTAL HEMATOLOGY (2007)
A constitutively active SPTBNI-FLT3 fusion in atypical chronic myeloid leukemia is sensitive to tyrosine kinase inhibitors and immunotherapy
Francis H. Grand et al.
EXPERIMENTAL HEMATOLOGY (2007)
FLT3 is fused to ETV6 in a myeloproliferative disorder with hypereosinophilia and a t(12;13) (p13;q12) translocation
Ha Vu et al.
LEUKEMIA (2006)
Myelodysplastic/myeloproliferative disease with erythropoietic hyperplasia (erythroid preleukemia) and the unique translocation (8;9)(p23;p24): first description of a case
S Heiss et al.
HUMAN PATHOLOGY (2005)
The t(8;9)(p22;p24) is a recurrent abnormality in chronic and acute leukemia that fuses PCM1 to JAK2
A Reiter et al.
CANCER RESEARCH (2005)
FIP1L1-PDGFRA fusion:: prevalence and clinicopathologic correlates in 89 consecutive patients with moderate to severe eosinophilia
A Pardanani et al.
BLOOD (2004)
A direct binding site for Grb2 contributes to transformation and leukemogenesis by the Tel-Abl (ETV6-Abl) tyrosine kinase
RP Million et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
Share Paper
